Promega Corporation has filed a patent infringement lawsuit against Aobious, Inc. regarding a key component of NanoLuc® luciferase technology. The lawsuit aims to halt unauthorized sales of furimazine substrates by Aobious. Furimazine substrates are protected by multiple active patents held by Promega. Madison, WI USA. — Promega Corporation announced today that it has filed a […]
Continued innovation of proprietary cell-free cloning technology has improved synthesis success rates, enabling pricing as low as $0.15 per base pair. SAN CARLOS, Calif. — Elegen, a leader in next-generation cell-free DNA manufacturing, today announced a 25% reduction in price for ENFINIA™ DNA, making industry-leading long, complex, NGS-verified DNA more accessible to researchers and biotech […]
Partnership Expands Oncology Research Possibilities INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research. Under a co-exclusive distribution agreement between the two companies, Beckman Coulter Life […]
Collaboration will build on Oxford Nanopore’s ongoing investment in Canada and support future research initiatives aimed at addressing health disparities Genome Canada and Oxford Nanopore Technologies today announced a collaboration aimed at significantly enhancing genomics research across Canada. Through the Canadian Precision Health Initiative (CPHI), the collaboration will help researchers and clinicians build a comprehensive […]
SEATTLE – Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin products. This comes on the heels of Parse invalidating the patents that 10x Genomics had asserted against Parse’s Evercode Whole Transcriptome products and the subsequent cancellation […]
AmplideX® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes. MINNEAPOLIS and OXFORD, England — Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore Technologies to launch the AmplideX® Nanopore Carrier Plus Kit, a new genetic panel and supporting analysis software for carrier screening research. This innovative kit […]
10x Genomics’ ATAC-Seq patents found valid and infringed PLEASANTON, Calif. — 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District of Delaware, Parse agreed – […]
UPPSALA, Sweden and BOSTON — MAGic BioProcessing is thrilled to welcome Ben Krol as the new Director of Sales & Business Development -North America East. Ben joins MAGic BioProcessing from Ecolab and brings extensive expertise in chromatography resins and a deep understanding of the evolving needs of biotech and pharmaceutical industry. His insights into downstream processing and his ability to align technology […]
Oxford Nanopore Technologies collaborates with the University of Tübingen and European sites to consolidate Oxford Nanopore sequencing as a first-line diagnostic tool. Oxford Nanopore Technologies today announces its support for the European Long Read Innovation Network (ELRIN), a novel European consortium led by experts from the University of Tübingen. This initiative aims to advance sequencing-based […]
Shimadzu Corporation hereby notifies that at the Board of Directors meeting held on February 27, 2025 based on the deliberations and recommendations of the Appointment and Compensation Committee, the attached list of changes to Executive Officers and Corporate Officers were decided, to be effective as of April 1, and the attached list of executive member […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
